tiprankstipranks
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market

Allergy Therapeutics (AGY) Cash flow

Compare
16 Followers

Allergy Therapeutics Cash Flow

GB:AGY's free cash flow for Q4 2023 was £-23.39M. For the 2023 fiscal year, GB:AGY's free cash flow was decreased by £46.00K and operating cash flow was £-21.85M. See a summary of the company’s cash flow.
Cash Flow
Jun 24Jun 23Jun 22Jun 21Jun 20
Operating Cash Flow
£ -32.14M£ -30.92M£ -14.11M£ 8.52M£ 12.28M
Investing Cash Flow
£ -1.20M£ -4.67M£ -3.06M£ -2.76M£ -2.77M
Financing Cash Flow
£ 31.43M£ 29.91M£ -2.64M£ -2.03M£ -110.00K
End Cash Position
£ 12.91M£ 14.85M£ 20.52M£ 40.27M£ 36.96M
Free Cash Flow
£ -35.54M£ -35.59M£ -17.17M£ 5.95M£ 9.73M
Currency in GBP

Allergy Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis